Repligen Corp. (RGEN)
165.18
+0.50
(+0.30%)
USD |
NASDAQ |
Sep 11, 16:00
165.00
-0.18
(-0.11%)
After-Hours: 20:00
Repligen Price to Book Value : 4.413 for Sept. 11, 2026
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| September 11, 2026 | 4.413 |
| September 10, 2026 | 4.400 |
| September 09, 2026 | 4.410 |
| September 08, 2026 | 4.503 |
| September 04, 2026 | 4.478 |
| September 03, 2026 | 4.532 |
| September 02, 2026 | 4.620 |
| September 01, 2026 | 4.542 |
| August 31, 2026 | 4.835 |
| August 28, 2026 | 4.709 |
| August 27, 2026 | 4.863 |
| August 26, 2026 | 4.817 |
| August 25, 2026 | 4.854 |
| August 24, 2026 | 4.852 |
| August 21, 2026 | 4.839 |
| August 20, 2026 | 4.817 |
| August 19, 2026 | 4.712 |
| August 18, 2026 | 4.439 |
| August 17, 2026 | 4.516 |
| August 14, 2026 | 4.457 |
| August 13, 2026 | 4.475 |
| August 12, 2026 | 4.427 |
| August 11, 2026 | 4.402 |
| August 10, 2026 | 4.359 |
| August 07, 2026 | 4.379 |
| Date | Value |
|---|---|
| August 06, 2026 | 4.260 |
| August 05, 2026 | 4.237 |
| August 04, 2026 | 4.002 |
| August 03, 2026 | 3.929 |
| July 31, 2026 | 3.767 |
| July 30, 2026 | 3.837 |
| July 29, 2026 | 3.773 |
| July 28, 2026 | 3.883 |
| July 27, 2026 | 3.502 |
| July 24, 2026 | 3.526 |
| July 23, 2026 | 3.676 |
| July 22, 2026 | 3.743 |
| July 21, 2026 | 3.66 |
| July 20, 2026 | 3.887 |
| July 17, 2026 | 3.934 |
| July 16, 2026 | 3.969 |
| July 15, 2026 | 3.956 |
| July 14, 2026 | 3.931 |
| July 13, 2026 | 3.871 |
| July 10, 2026 | 3.854 |
| July 09, 2026 | 3.846 |
| July 08, 2026 | 3.671 |
| July 07, 2026 | 3.736 |
| July 06, 2026 | 3.779 |
| July 02, 2026 | 3.804 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| BioLife Solutions, Inc. | 4.068 |
| Anika Therapeutics, Inc. | 2.034 |
| Danaher Corp. | 2.676 |
| Liquidia Corp. | 30.48 |
| Harmony Biosciences Holdings, Inc. | 2.415 |
Price to Book Value Related Metrics
| PE Ratio | 225.13 |
| PS Ratio | 11.91 |
| Price to Free Cash Flow | 84.91 |
| Price | 165.18 |
| Earnings Yield | 0.44% |
| Market Cap | 9.321B |
| Operating PE Ratio | 131.87 |
| Normalized PE Ratio | 202.38 |